Acepodia Presents Positive Interim Phase 1 Feasibility Data for Antibody Cell Effector Therapy, ACE1702, in Advanced HER2-Positive Tumors
Interim results from ongoing Phase 1 dose-escalation study demonstrate safety and tolerability of repeat dosing…
The UAE AI Curriculum Fits in 36 Periods. The Training Does Not.
The 7.7-Million-Job Industry That Still Runs on Phone Calls
OMP Extends UnisonIQ with Agent Library and Agent Studio: AI Agents that Produce Executable Supply Chain Plans
UNMOVE Launches Seven-Day Pass and Short-Cycle Personal Training for APEC Visitors in Shenzhen
Wintermar Offshore (WINS:JK) Reports Results for Third Quarter Ending 30 September 2026